|
1
|
Kaplan JE, Hanson D, Dworkin MS, Frederick
T, Bertolli J, Lindegren ML, Holmberg S and Jones JL: Epidemiology
of human immunodeficiency virus-associated opportunistic infections
in the United States in the era of highly active antiretroviral
therapy. Clin Infect Dis. 30((Suppl 1)): S5–S14. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Curtis JR, Yarnold PR, Schwartz DN,
Weinstein RA and Bennett CL: Improvements in outcomes of acute
respiratory failure for patients with human immunodeficiency
virus-related Pneumocystis carinii pneumonia. Am J Respir
Crit Care Med. 162:393–398. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
The National: Institutes of H
ealth-University of California Expert Panel for Corticosteroids as
Adjunctive Therapy for Pneumocystis Pneumonia: Consensus statement
on the use of corticosteroids as adjunctive therapy for
pneumocystis pneumonia in the acquired immunodeficiency syndrome. N
Engl J Med. 323:1500–1504. 1990.PubMed/NCBI
|
|
4
|
Klein NC, Duncanson FP, Lenox TH,
Forszpaniak C, Sherer CB, Quentzel H, Nunez M, Suarez M, Kawwaff O,
Pitta-Alvarez A, et al: Trimethoprim-sulfamethoxazole versus
pentamidine for Pneumocystis carinii pneumonia in AIDS
patients: Results of a large prospective randomized treatment
trial. AIDS. 6:301–305. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Briel M, Bucher HC, Boscacci R and Furrer
H: Adjunctive corticosteroids for Pneumocystis jiroveci
pneumonia in patients with HIV-infection. Cochrane Database Syst
Rev. 3:CD0061502006.PubMed/NCBI
|
|
6
|
Panel on Opportunistic Infections in
HIV-Infected Adults and Adolescents, Guidelines for Prevention and
Treatment of Opportunistic Infections in HIV-Infected Adults and
Adolescents: Recommendations from the Centers for Disease Control
and Prevention the National Institutes of Health, and the HIV
Medicine Association of the Infectious Diseases Society of America.
http://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdfAccessed.
November 20–2015
|
|
7
|
Wolfe F, Caplan L and Michaud K: Treatment
for rheumatoid arthritis and the risk of hospitalization for
pneumonia, Associations with prednisone, disease-modifying
antirheumatic drugs, and anti-tumor necrosis factor therapy.
Arthritis Rheum. 54:628–634. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ko JH, Peck KR, Lee WJ, Lee JY, Cho SY, Ha
YE, Kang CI, Chung DR, Kim YH, Lee NY, et al: Clinical presentation
and risk factors for cytomegalovirus colitis in immunocompetent
adult patients. Clin Infect Dis. 60:e20–e26. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
DerSimonian R and Laird N: Meta-analysis
in clinical trials. Control Clin Trials. 7:177–187. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Begg CB and Mazumdar M: Operating
characteristics of a rank correlation test for publication bias.
Biometrics. 50:1088–1101. 1994. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Terblanche AJ, Green RJ, Rheeder P and
Wittenberg DF: Adjunctive corticosteroid treatment of clinical
Pneumocystis jiroveci pneumonia in infants less than 18
months of age - a randomised controlled trial. S Afr Med J.
98:287–290. 2008.PubMed/NCBI
|
|
12
|
Gagnon S, Boota AM, Fischl MA, Baier H,
Kirksey OW and La Voie L: Corticosteroids as adjunctive therapy for
severe Pneumocystis carinii pneumonia in the acquired
immunodeficiency syndrome. A double-blind, placebo-controlled
trial. N Engl J Med. 323:1444–1450. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bozzette SA, Sattler FR, Chiu J, Wu AW,
Gluckstein D, Kemper C, Bartok A, Niosi J, Abramson I, Coffman J,
et al: California collaborative treatment group: A controlled trial
of early adjunctive treatment with corticosteroids for
Pneumocystis carinii pneumonia in the acquired
immunodeficiency syndrome. N Engl J Med. 323:1451–1457. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nielsen TL, Schattenkerk Eeftinck JK,
Jensen BN, Lundgren JD, Gerstoft J, van Steenwijk RP, Bentsen K,
Frissen PH, Gaub J, Orholm M, et al: Adjunctive corticosteroid
therapy for Pneumocystis carinii pneumonia in AIDS: A
randomized European multicenter open label study. J Acquir Immune
Defic Syndr. 5:726–731. 1992.PubMed/NCBI
|
|
15
|
Montaner JS, Lawson LM, Levitt N, Belzberg
A, Schechter MT and Ruedy J: Corticosteroids prevent early
deterioration in patients with moderately severe Pneumocystis
carinii pneumonia and the acquired immunodeficiency syndrome
(AIDS). Ann Intern Med. 113:14–20. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Walmsley S, Levinton C, Brunton J,
Muradali D, Rappaport D, Bast M, Spence D and Salit I: A
multicenter randomized double-blind placebo-controlled trial of
adjunctive corticosteroids in the treatment of Pneumocystis
carinii pneumonia complicating the acquired immune deficiency
syndrome. J Acquir Immune Defic Syndr Hum Retrovirol. 8:348–357.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Thomas CF: Jr andL imper AH: Pneumocystis
pneumonia. N Engl J Med. 350:2487–2498. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ewald H, Raatz H, Boscacci R, Furrer H,
Bucher HC and Briel M: Adjunctive corticosteroids for
Pneumocystis jiroveci pneumonia in patients with HIV
infection. Cochrane Database Syst Rev. 4:D61502015.
|
|
19
|
Benson CA, Kaplan JE, Masur H, Pau A and
Holmes KK: CDC; National Institutes of Health; Infectious Diseases
Society of America: Treating opportunistic infections among
HIV-infected adults and adolescents. Recommendations from CDC, the
National Institutes of Health and the HIV Medicine
Association/Infectious Diseases Society of America. MMWR Recomm
Rep. 53(RR-15): 1–112. 2004.PubMed/NCBI
|
